Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2008
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigaretteArthur L Brody, Mark A Mandelkern, Richard E Olmstead, et al.
Oncotarget|October 27, 2012
Effects of ectopic expression of NGAL on doxorubicin sensitivityWilliam H Chappell, Stephen L Abrams, Giuseppe Montalto, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Current Pharmaceutical Design|October 22, 2013
Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLCLudovica Ciuffreda, Ursula Cesta Incani, Linda S Steelman, et al.
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Aging|February 5, 2020
New landscapes and horizons in hepatocellular carcinoma therapyMelchiorre Cervello, Maria R Emma, Giuseppa Augello, et al.
Transplantation Direct|March 20, 2023
An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United StatesAshley Yoo, Alexandria Riedel, Ian Qian, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Pageof 26